C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2004
12/02/2004	US20040242568 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242566 Dipeptidyl peptidase inhibitors
12/02/2004	US20040242554 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants
12/02/2004	US20040242494 Caspase inhibitors and uses thereof
12/02/2004	CA2525945A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
12/02/2004	CA2525501A1 Tetrahydroisoquinoline derivatives as ppar-.alpha. activators
12/02/2004	CA2525292A1 Phenyl quinolines and their use as estrogenic agents
12/02/2004	CA2525102A1 Benzothiazole derivatives and use thereof in the treatment of diseases relates to the adenosine a2a receptor
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481975A1 Inhibitors of farnesyl protein transferase
12/01/2004	EP1481972A1 Cyclic compound, process for producing the same, and pest control agent
12/01/2004	EP1481970A1 Novel herbicides
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004	EP1480986A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
12/01/2004	EP1480976A1 Thiazole derivatives as npy receptor antagonists
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480958A1 Uracil-thioether
12/01/2004	EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480951A1 Synthesis of indole thiazole compounds as ligands for the ah receptor
12/01/2004	EP1480643A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
12/01/2004	EP1480642A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP1480641A1 Substituted thiazoles and oxazoles that modulate ppar activity
12/01/2004	EP1480640A1 Peroxisome proliferator activated receptor modulators
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0886637B1 Inhibitors of microsomal triglyceride transfer protein and method
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551876A 6-aryl-4-aminopicolinates and their use as herbicides
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1550498A Substituted guanidine derivatives
12/01/2004	CN1177846C Oxa(thia) diazolylpyridazinone derivative and its preparing process and application
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177823C Pesticides
11/2004
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825230 Spiro and dispiro 1,2,4-trixolane antimalarials
11/30/2004	US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825191 Benzodiazepine derivatives
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825188 More potent inhibitors of the vitronectin receptor than the fibrinogen
11/25/2004	WO2004101561A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
11/25/2004	WO2004101560A1 Processes for making thiazolidinedione derivatives and compounds thereof
11/25/2004	WO2004101559A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2004	WO2004101558A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	WO2004101553A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
11/25/2004	WO2004101552A1 Oxazolidinone derivatives as antibacterial agents
11/25/2004	WO2004101546A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/25/2004	WO2004101544A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	WO2004101533A1 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands
11/25/2004	WO2004101528A2 Isoquinoline derivatives and their use as gfat inhibitors
11/25/2004	WO2004101522A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	WO2004101520A1 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists
11/25/2004	WO2004101518A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	WO2004101512A2 Naphthyridine integrase inhibitors
11/25/2004	WO2004100998A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid
11/25/2004	WO2004100946A1 1- (2h-pyrazol -3-yl) -3yl) {4-`1- (benzoyl) -piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhbitors of p38 kinase and/or tnf inhibitors for the treatment of imflammations
11/25/2004	WO2004100881A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	WO2004100865A2 New benzimidazole derivatives
11/25/2004	WO2004089942A3 Benzimidazolidinone derivatives as muscarinic agents
11/25/2004	WO2004027378A3 Luminescence-based methods and probes for measuring cytochrome p450 activity
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236114 1-[(hetero)aryloxy- or -thio-hydroxyalkyl]-substituted imidazole-4-carboxamides, e.g., 1-(5-(1,1'-biphenyl-3-yloxy)-2-hydroxy-3-pentyl]imidazole-4-carboxamide; treating rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis, sunburn, eczema, conjunctivitis, asthma, & bronchitis
11/25/2004	US20040236111 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/25/2004	US20040236109 Tetrahydroquinoline derivatives
11/25/2004	US20040236105 Triazole derivatives useful in therapy
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy
11/25/2004	US20040235920 Novel use of substituted aminomethyl chromans for the treatment of movement disorders and of adverse effects induced by drugs administered to treat extrapyramidal movement disorders
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235917 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans
11/25/2004	US20040235916 Thiazolyl amides and their use as antiviral drugs
11/25/2004	US20040235915 Benzothiazole derivatives
11/25/2004	US20040235913 drug abuse; psychological disorders; antidepressants; sexual disorders; hypotensive agents; anxiolytic agernts; Alzheimer's disease; schizophrenia; Parkinson's disease; sleep disorders; reastless leg syndrome; irritable bowel syndrome
11/25/2004	US20040235900 Antimicrobial oxazolifinones with improved pharmacokinetic profile and safety advantages
11/25/2004	US20040235897 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
11/25/2004	US20040235896 Certain azacycloalkyl substituted acetic acid derivatives
11/25/2004	US20040235886 Gyrase inhibitors and uses thereof
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235842 For therapy of Alzheimer's disease, depression
11/25/2004	US20040235834 For therapy and prophylaxis of immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, proliferative disorders, immunologically-mediated diseases, or respiratory disorders
11/25/2004	US20040235833 5-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl) phenyl]ethyl}amino) propyl]-N-(2-methoxybenzyl)-1H-indole-2-carboxamide for example; asthma, bronchitis, and emphysema; beta-2 adrenergic receptor agonists
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004	US20040235828 For therapy and prophylaxis of thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexia, angina pectoris, restenosis after angioplasty, claudicatio intermittens, migraine, tumours, tumour diseases and/or tumour metastases
11/25/2004	US20040235826 Tyrosine kinase ihnibitors
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235816 Administering compounds such as 1-benzhydryl-3-[(methylsulfonyl)(phenyl)methylene]azetidine for therapy of schizophrenia, Parkinson's disease, and Alzeimer's disease
11/25/2004	US20040235798 Identifying a small organic molecule having a core structure, the small organic molecule having a cytotoxic antifungal activity; andpreparing a compound comprising the core structure of the identified cytotoxic antifungal agent
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040234454 Pathological tissue detection and treatment employing targeted benzoindole optical agents
11/25/2004	CA2526065A1 Benzimidazole-derivatives as factor xa inhibitors
11/25/2004	CA2525860A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
11/25/2004	CA2525858A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
11/25/2004	CA2525849A1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525316A1 Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
11/25/2004	CA2524958A1 Isoquinoline derivatives and their use as gfat inhibitors

1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 628